By measuring circulating aHER2 [5–8, 16] by dPCR, and sHER2 [12] by a sandwich ELISA, this assay recapitulates two-dimensional HER2 status assessment in tumor tissues, hence HER2-2D. This evidence concerns the gene ERBB2 and neoplasm.